Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Therapeutic Monoclonal Antibodies for Influenza A Virus Infection
EF 2021-22
Résumé
Influenza viruses are one of the most widespread pathogens across the globe. In addition to seasonal epidemics, influenza viruses have also caused four pandemics in the last century. Antibodies elicited by seasonal influenza vaccines mainly target a specific domain of hemagglutinin, a protein expressed on the surface of influenza viruses. This domain is fairly variable and can mutate, resulting in years where there is little protection provided by the vaccine. My project aims to characterize an antibody that binds to a different part of hemagglutinin that is less variable. Intravenous injection of this antibody could be used as a therapeutic to help treat patients who do not respond to antivirals. It could also be used preventatively for high-risk individuals such as the elderly and the immunocompromised. I will determine which strains of influenza the antibody can recognize. I will also examine the mechanisms by which the antibody provides protection. Finally, I will administer the antibody to mice to determine if it can prevent clinical symptoms of infection. It is important to understand how this antibody provides protection before we can evaluate its efficacy in humans. Access to more effective therapeutics will help control the spread of seasonal influenza virus infection and could help mitigate the spread and severity of future pandemics.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466978
Name
Tugg Yona
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Therapeutic Monoclonal Antibodies for Influenza A Virus Infection
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Discovery; Fc Effector Function; Influenza A Virus; Monoclonal Antibody; Passive Immunization; Virus
Abstract
Influenza viruses are one of the most widespread pathogens across the globe. In addition to seasonal epidemics, influenza viruses have also caused four pandemics in the last century. Antibodies elicited by seasonal influenza vaccines mainly target a specific domain of hemagglutinin, a protein expressed on the surface of influenza viruses. This domain is fairly variable and can mutate, resulting in years where there is little protection provided by the vaccine. My project aims to characterize an antibody that binds to a different part of hemagglutinin that is less variable. Intravenous injection of this antibody could be used as a therapeutic to help treat patients who do not respond to antivirals. It could also be used preventatively for high-risk individuals such as the elderly and the immunocompromised. I will determine which strains of influenza the antibody can recognize. I will also examine the mechanisms by which the antibody provides protection. Finally, I will administer the antibody to mice to determine if it can prevent clinical symptoms of infection. It is important to understand how this antibody provides protection before we can evaluate its efficacy in humans. Access to more effective therapeutics will help control the spread of seasonal influenza virus infection and could help mitigate the spread and severity of future pandemics.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tugg, Yona
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~